首页 > 最新文献

Obstetrics & Gynecology eJournal最新文献

英文 中文
Pregnancy and Alcohol Purchases: Evidence from Scanner Data 怀孕和酒精购买:来自扫描仪数据的证据
Pub Date : 2019-07-15 DOI: 10.2139/ssrn.3446559
Aljoscha Janssen, Elle Parslow
We analyze household-level changes in alcohol consumption in response to pregnancy. Using scanner data, we identify households with a pregnant household member. Within an event study and a dynamic difference-in-differences estimation, we find that during a first pregnancy, households reduce their alcohol purchases by 35%. After pregnancy, purchases of alcohol are 31% lower than before pregnancy. We do not find any effect during the second pregnancy. We argue that lower consumption during pregnancy changes habits and reduces consumption in the long term. We exclude other explanations and comment on policy implications.
我们分析了家庭饮酒量在怀孕期间的变化。使用扫描仪数据,我们识别有怀孕家庭成员的家庭。在一项事件研究和动态差异估计中,我们发现,在第一次怀孕期间,家庭减少了35%的酒精购买。怀孕后,酒精的购买量比怀孕前低31%。我们在第二次怀孕期间没有发现任何影响。我们认为,在怀孕期间减少消费改变习惯,并减少长期消费。我们排除了其他解释,并对政策影响进行了评论。
{"title":"Pregnancy and Alcohol Purchases: Evidence from Scanner Data","authors":"Aljoscha Janssen, Elle Parslow","doi":"10.2139/ssrn.3446559","DOIUrl":"https://doi.org/10.2139/ssrn.3446559","url":null,"abstract":"We analyze household-level changes in alcohol consumption in response to pregnancy. Using scanner data, we identify households with a pregnant household member. Within an event study and a dynamic difference-in-differences estimation, we find that during a first pregnancy, households reduce their alcohol purchases by 35%. After pregnancy, purchases of alcohol are 31% lower than before pregnancy. We do not find any effect during the second pregnancy. We argue that lower consumption during pregnancy changes habits and reduces consumption in the long term. We exclude other explanations and comment on policy implications.","PeriodicalId":335359,"journal":{"name":"Obstetrics & Gynecology eJournal","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129093520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A Portfolio Approach to Accelerate Therapeutic Innovation in Ovarian Cancer 加速卵巢癌治疗创新的组合方法
Pub Date : 2018-10-25 DOI: 10.2139/ssrn.3286330
Shomesh E. Chaudhuri, Katherine A. Cheng, A. Lo, S. Pepke, Sergio Rinaudo, L. Roman, R. Spencer
Biomedical innovation in oncology has become riskier and more expensive, precipitating a withdrawal of private sector funding from the sector. In this article, we consider a portfolio-based approach to funding in which multiple distinct ovarian cancer treatment candidates are funded within a single structure. Twenty-five potential early-stage drug development projects were identified for inclusion in a hypothetical portfolio through interviews with gynecological oncologists and leading experts, a review of ovarian cancer-related trials registered in the ClinicalTrials.gov database, and an extensive literature review. The annualized returns of this portfolio were simulated under a purely private sector structure both with and without partial funding from philanthropic grants, and a public-private partnership that included government guarantees. We find that public-private structures of this type can increase expected returns and reduce tail risk, allowing greater amounts of private sector capital to fund early-stage research and development.
肿瘤学领域的生物医学创新已变得风险更大、成本更高,促使私营部门从该领域撤出资金。在本文中,我们考虑了一种基于投资组合的资助方法,其中多种不同的卵巢癌治疗候选药物在单一结构中获得资助。通过与妇科肿瘤学家和主要专家的访谈、对ClinicalTrials.gov数据库中注册的卵巢癌相关试验的回顾以及广泛的文献回顾,确定了25个潜在的早期药物开发项目,并将其纳入假设的投资组合。这个投资组合的年化回报是在一个纯私营部门结构下模拟的,包括有和没有部分来自慈善捐赠的资金,以及包括政府担保的公私合作伙伴关系。我们发现,这种类型的公私结构可以增加预期回报,降低尾部风险,允许更多的私营部门资本资助早期研究和开发。
{"title":"A Portfolio Approach to Accelerate Therapeutic Innovation in Ovarian Cancer","authors":"Shomesh E. Chaudhuri, Katherine A. Cheng, A. Lo, S. Pepke, Sergio Rinaudo, L. Roman, R. Spencer","doi":"10.2139/ssrn.3286330","DOIUrl":"https://doi.org/10.2139/ssrn.3286330","url":null,"abstract":"Biomedical innovation in oncology has become riskier and more expensive, precipitating a withdrawal of private sector funding from the sector. In this article, we consider a portfolio-based approach to funding in which multiple distinct ovarian cancer treatment candidates are funded within a single structure. Twenty-five potential early-stage drug development projects were identified for inclusion in a hypothetical portfolio through interviews with gynecological oncologists and leading experts, a review of ovarian cancer-related trials registered in the ClinicalTrials.gov database, and an extensive literature review. The annualized returns of this portfolio were simulated under a purely private sector structure both with and without partial funding from philanthropic grants, and a public-private partnership that included government guarantees. We find that public-private structures of this type can increase expected returns and reduce tail risk, allowing greater amounts of private sector capital to fund early-stage research and development.","PeriodicalId":335359,"journal":{"name":"Obstetrics & Gynecology eJournal","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127172243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Fertility and Labor Market Responses to Reductions in Mortality 生育率和劳动力市场对死亡率下降的反应
Pub Date : 2018-07-13 DOI: 10.2139/SSRN.3213304
S. Bhalotra, Atheendar S. Venkataramani, Selma Walther
We investigate women's fertility, labor and marriage market responses to large declines in child and maternal mortality that occurred following a major medical innovation in the US. In response to the decline in child mortality, women delayed childbearing and had fewer children overall. Fewer women had three or more children, and a larger share remained childless. We present a new theory of the extensive margin response, premised upon improvements in child survival reducing the time women need to achieve their target number of children. This prompts fertility delay and labor market entry which, coupled with wage or fecundity shocks, can result in childlessness. Consistent with these predictions, we find that reductions in child mortality increased women's labor force participation, improved their occupational status and reduced their chances of ever having married. Maternal mortality decline had opposing effects on all of these outcomes.
我们调查了妇女的生育能力,劳动力和婚姻市场对儿童和孕产妇死亡率大幅下降的反应,这发生在美国的一项重大医疗创新之后。为了应对儿童死亡率的下降,妇女推迟了生育,总体上减少了生育。有三个或更多孩子的女性越来越少,没有孩子的比例也越来越大。我们提出了广泛边际反应的新理论,前提是提高儿童存活率,减少妇女需要实现其目标数量的孩子的时间。这导致生育延迟和劳动力市场进入,再加上工资或生育能力的冲击,可能导致无子女。与这些预测一致的是,我们发现儿童死亡率的降低提高了妇女的劳动力参与率,改善了她们的职业地位,降低了她们结婚的机会。产妇死亡率下降对所有这些结果产生相反的影响。
{"title":"Fertility and Labor Market Responses to Reductions in Mortality","authors":"S. Bhalotra, Atheendar S. Venkataramani, Selma Walther","doi":"10.2139/SSRN.3213304","DOIUrl":"https://doi.org/10.2139/SSRN.3213304","url":null,"abstract":"We investigate women's fertility, labor and marriage market responses to large declines in child and maternal mortality that occurred following a major medical innovation in the US. In response to the decline in child mortality, women delayed childbearing and had fewer children overall. Fewer women had three or more children, and a larger share remained childless. We present a new theory of the extensive margin response, premised upon improvements in child survival reducing the time women need to achieve their target number of children. This prompts fertility delay and labor market entry which, coupled with wage or fecundity shocks, can result in childlessness. Consistent with these predictions, we find that reductions in child mortality increased women's labor force participation, improved their occupational status and reduced their chances of ever having married. Maternal mortality decline had opposing effects on all of these outcomes.","PeriodicalId":335359,"journal":{"name":"Obstetrics & Gynecology eJournal","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128917118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Cost Effectiveness of Local vs. Oral Antibiotic in Non-Pregnant Women with Vaginal Discharge Suggestive of Bacterial Vaginosis 阴道分泌物提示细菌性阴道病的非妊娠妇女局部与口服抗生素的成本效益
Pub Date : 2012-07-10 DOI: 10.2139/SSRN.2194561
Javier Díaz Rojas, M. García Molina, Liliana Chicaíza, Alexander Moreno Calderón, V. Prieto Martínez, H. Gaitán, Ariel Ruiz Prieto, Andrea Rodríguez Hernández, C. Rincón, J. Urrego
Objective: To estimate the cost-effectiveness of local vs. oral antibiotic in non-pregnant women with vaginal discharge suggestive of bacterial vaginosis.Methods: We compared four combinations of antibiotics for the first option and for the treatment of clinical failure: vaginal clindamycin and tinidazol PO, single dose; vaginal clindamycin and secnidazol PO, single dose; tinidazol PO, single dose y vaginal clindamycin; secnidazol PO, single dose, and vaginal clindamycin. A Markov model was built in TreeAge® to represent the natural history of bacterial vaginosis. Treatment changes in the face of recurrence without adverse events where modeled separately as a decision tree. The perspective was that of the health system, including all direct costs. All monetary amounts were expressed in Colombian pesos of 2010. The outcome was clinical improvement. Effectiveness, security, persistence and recurrence data were extracted from the literature. The incremental cost-effectiveness ratio was calculated; univariate and probabilistic sensitivity analyses were performed.Results: Both for the general and the particular cases, treatment with vaginal clindamycin as the first choice and tinidazole PO, single dose, to treat recurrence and persistence with adverse events is a dominant strategy because it is less costly and more effective than the other treatment regimes evaluated. Per 1.000 patients, the cost of the dominant alternative is $ 16.795.411 COP with 985,6 clinical improvements in the general case and $ $ 23.979.230 COP with 903,4 clinical improvements in the particular case.Conclusion: Vaginal clindamycin as the first choice for treatment of bacterial vaginosis and tinidazole PO, single dose, to treat recurrence and persistence with adverse events of clindamycin is cost effective in Colombia. The results were robust to variations in the parameters of the model.
目的:评估局部与口服抗生素治疗有阴道分泌物提示细菌性阴道病的非妊娠妇女的成本-效果。方法:比较第一选择和临床失败治疗的四种抗生素组合:阴道克林霉素和替硝唑PO单剂量;阴道克林霉素、塞克硝唑PO单剂;替硝唑PO单剂阴道克林霉素;单剂量塞克硝唑PO和阴道克林霉素。在TreeAge®中建立了一个马尔可夫模型来代表细菌性阴道病的自然史。无不良事件复发时的治疗变化分别建模为决策树。从卫生系统的角度出发,包括所有直接费用。所有货币金额均以2010年哥伦比亚比索表示。结果是临床改善。从文献中提取有效性、安全性、持久性和复发性数据。计算增量成本-效果比;进行了单变量和概率敏感性分析。结果:对于一般病例和特殊病例,阴道克林霉素治疗为首选,替硝唑单剂量治疗复发和持续性不良事件是主要的治疗策略,因为它比其他治疗方案更便宜,更有效。每1000例患者中,优势替代方案的成本为16.795.411美元COP,一般病例中有9856例临床改善,特殊病例中有903.4例临床改善,成本为23.979.230美元COP。结论:阴道克林霉素作为治疗细菌性阴道病的首选药物,替硝唑PO单次给药,治疗克林霉素复发和持续性不良事件在哥伦比亚是具有成本效益的。结果对模型参数的变化具有鲁棒性。
{"title":"Cost Effectiveness of Local vs. Oral Antibiotic in Non-Pregnant Women with Vaginal Discharge Suggestive of Bacterial Vaginosis","authors":"Javier Díaz Rojas, M. García Molina, Liliana Chicaíza, Alexander Moreno Calderón, V. Prieto Martínez, H. Gaitán, Ariel Ruiz Prieto, Andrea Rodríguez Hernández, C. Rincón, J. Urrego","doi":"10.2139/SSRN.2194561","DOIUrl":"https://doi.org/10.2139/SSRN.2194561","url":null,"abstract":"Objective: To estimate the cost-effectiveness of local vs. oral antibiotic in non-pregnant women with vaginal discharge suggestive of bacterial vaginosis.Methods: We compared four combinations of antibiotics for the first option and for the treatment of clinical failure: vaginal clindamycin and tinidazol PO, single dose; vaginal clindamycin and secnidazol PO, single dose; tinidazol PO, single dose y vaginal clindamycin; secnidazol PO, single dose, and vaginal clindamycin. A Markov model was built in TreeAge® to represent the natural history of bacterial vaginosis. Treatment changes in the face of recurrence without adverse events where modeled separately as a decision tree. The perspective was that of the health system, including all direct costs. All monetary amounts were expressed in Colombian pesos of 2010. The outcome was clinical improvement. Effectiveness, security, persistence and recurrence data were extracted from the literature. The incremental cost-effectiveness ratio was calculated; univariate and probabilistic sensitivity analyses were performed.Results: Both for the general and the particular cases, treatment with vaginal clindamycin as the first choice and tinidazole PO, single dose, to treat recurrence and persistence with adverse events is a dominant strategy because it is less costly and more effective than the other treatment regimes evaluated. Per 1.000 patients, the cost of the dominant alternative is $ 16.795.411 COP with 985,6 clinical improvements in the general case and $ $ 23.979.230 COP with 903,4 clinical improvements in the particular case.Conclusion: Vaginal clindamycin as the first choice for treatment of bacterial vaginosis and tinidazole PO, single dose, to treat recurrence and persistence with adverse events of clindamycin is cost effective in Colombia. The results were robust to variations in the parameters of the model.","PeriodicalId":335359,"journal":{"name":"Obstetrics & Gynecology eJournal","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121991884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research and Science Today 今日研究与科学
Pub Date : 2011-09-15 DOI: 10.2139/SSRN.2364857
E. Ignat, Livia-Andreea Pătru, Cristina Ciora, Mădălina Laura Cuciurianu, Dragoș Tîrnoveanu, F. Mărcău, R. Munteanu, S. Sulima, Andreea-Emilia Duta, P. Duta, C. Borcosi, A. Lavric, V. Popa, S. Zaharia, C. Morariu, Alice Mihaela Postavaru, D. Paraschiv, Elena Paraschiv, Gavril Paraschiv, Ramona-Gabriela Paraschiv, V. Voinea, Blendea Sevastian, A. Cecal, M. Curelar, Elena Bran, Răzvan Bran, Oana Dumitrescu, A. Gheorghe, Monica Daniela Pop, C. Tătaru, Constantin Mihai, Miruna, O. Bodean, Diana, O. Munteanu, E. Brătilă, Bohâlțea, D. Davițoiu, M. Cirstoiu, Andra Ionescu, M. Diculescu, C. Ciora, Lucian Ionescu, B. Dorobat
Research and Science Today Journal is a publication founded in 2011 and it is dedicated to the students of all levels (license, master and doctoral) of faculties in the country and abroad. We want to offer the participants the opportunity to present their scientific works in the following areas: Social Sciences, Economic Sciences, Legal Sciences, Humanities, Education Sciences, Engineering, Medicine and Sport.This journal provides students the opportunity to create and/or to improve their abilities to write scientific papers. So each appearance (two appearances per year at which we can add supplements) contains a number of papers written by students, masters and doctoral from the faculties from the country or/and abroad. The journal promotes original studies contributing to the progress of knowledge and it is motivated by the need to address issues of theory and practice in the areas mentioned above.
《今日研究与科学》创刊于2011年,面向国内外各层次(硕士、硕士、博士)院校学生。我们希望为参与者提供机会,展示他们在以下领域的科学作品:社会科学、经济科学、法律科学、人文科学、教育科学、工程、医学和体育。本期刊为学生提供了创造和/或提高他们撰写科学论文能力的机会。因此,每次出版(每年出版两次,我们可以增加增刊)都包含了来自国内外院系的学生、硕士和博士撰写的大量论文。该杂志促进有助于知识进步的原创研究,其动机是需要解决上述领域的理论和实践问题。
{"title":"Research and Science Today","authors":"E. Ignat, Livia-Andreea Pătru, Cristina Ciora, Mădălina Laura Cuciurianu, Dragoș Tîrnoveanu, F. Mărcău, R. Munteanu, S. Sulima, Andreea-Emilia Duta, P. Duta, C. Borcosi, A. Lavric, V. Popa, S. Zaharia, C. Morariu, Alice Mihaela Postavaru, D. Paraschiv, Elena Paraschiv, Gavril Paraschiv, Ramona-Gabriela Paraschiv, V. Voinea, Blendea Sevastian, A. Cecal, M. Curelar, Elena Bran, Răzvan Bran, Oana Dumitrescu, A. Gheorghe, Monica Daniela Pop, C. Tătaru, Constantin Mihai, Miruna, O. Bodean, Diana, O. Munteanu, E. Brătilă, Bohâlțea, D. Davițoiu, M. Cirstoiu, Andra Ionescu, M. Diculescu, C. Ciora, Lucian Ionescu, B. Dorobat","doi":"10.2139/SSRN.2364857","DOIUrl":"https://doi.org/10.2139/SSRN.2364857","url":null,"abstract":"Research and Science Today Journal is a publication founded in 2011 and it is dedicated to the students of all levels (license, master and doctoral) of faculties in the country and abroad. We want to offer the participants the opportunity to present their scientific works in the following areas: Social Sciences, Economic Sciences, Legal Sciences, Humanities, Education Sciences, Engineering, Medicine and Sport.This journal provides students the opportunity to create and/or to improve their abilities to write scientific papers. So each appearance (two appearances per year at which we can add supplements) contains a number of papers written by students, masters and doctoral from the faculties from the country or/and abroad. The journal promotes original studies contributing to the progress of knowledge and it is motivated by the need to address issues of theory and practice in the areas mentioned above.","PeriodicalId":335359,"journal":{"name":"Obstetrics & Gynecology eJournal","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114120198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Malpractice Liability on the Specialty of Obstetrics and Gynecology 医疗事故责任对妇产科专业的影响
Pub Date : 2010-03-01 DOI: 10.3386/W15841
J. W. Reyes
Using data from a 2003 survey of 1,476 obstetrician-gynecologists, the effects of malpractice pressure on the specialty are investigated. Physicians report having made substantial changes to their practice in response to the general environment and to liability pressures. Regression analysis finds that liability pressure increases reports of income and practice reductions, but direct effects on actual income and productivity are less clear. Liability pressures may lead to a specialization effect, with some physicians concentrating more in obstetrics and others in gynecological surgery. Overall, the evidence suggests that liability pressure has moderate but significant effects on the specialty.
利用2003年对1476名妇产科医生的调查数据,调查了医疗事故压力对该专业的影响。医生报告说,为了应对一般环境和责任压力,他们已经对自己的做法做出了实质性的改变。回归分析发现,负债压力增加了收入和实践减少的报告,但对实际收入和生产力的直接影响不太清楚。责任压力可能导致专业化效应,一些医生更专注于产科,而另一些则专注于妇科手术。总体而言,证据表明责任压力对专业有适度但显著的影响。
{"title":"The Effect of Malpractice Liability on the Specialty of Obstetrics and Gynecology","authors":"J. W. Reyes","doi":"10.3386/W15841","DOIUrl":"https://doi.org/10.3386/W15841","url":null,"abstract":"Using data from a 2003 survey of 1,476 obstetrician-gynecologists, the effects of malpractice pressure on the specialty are investigated. Physicians report having made substantial changes to their practice in response to the general environment and to liability pressures. Regression analysis finds that liability pressure increases reports of income and practice reductions, but direct effects on actual income and productivity are less clear. Liability pressures may lead to a specialization effect, with some physicians concentrating more in obstetrics and others in gynecological surgery. Overall, the evidence suggests that liability pressure has moderate but significant effects on the specialty.","PeriodicalId":335359,"journal":{"name":"Obstetrics & Gynecology eJournal","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116385572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
期刊
Obstetrics & Gynecology eJournal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1